<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02869880</url>
  </required_header>
  <id_info>
    <org_study_id>2015-9033</org_study_id>
    <nct_id>NCT02869880</nct_id>
  </id_info>
  <brief_title>Trial of Enhanced Pre-Consent Discussion</brief_title>
  <official_title>Trial of Enhanced Pre-Consent Discussion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ImproveCareNow (ICN)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nested within the COMBINE pragmatic clinical trial, the investigators will conduct a cluster
      randomized controlled trial to determine whether, in parents (of children with Crohn's
      Disease) or patients &gt; 18 years old being approached for trial participation, a pre-consent
      discussion enhanced with decision aids is more effective than the standard pre-consent
      discussion in transferring knowledge to parents/patients related to trial participation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knowledge Related to Trial Participation</measure>
    <time_frame>prior to consent</time_frame>
    <description>Percent correct on 6-item Knowledge Related to Trial Participation survey</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of enrollment</measure>
    <time_frame>at consent</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Support subscale of decision conflict scale</measure>
    <time_frame>prior to consent</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Pediatric Crohn's Disease</condition>
  <arm_group>
    <arm_group_label>Standard Pre-consent Discussion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard pre-consent discussion for a clinical trial.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enhanced Pre-consent Discussion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The enhanced pre-consent discussion intervention is a tool that includes both textual and graphical information regarding the trial and an interactive component designed to initiate and facilitate conversations between all parties in the decision—parent, patient, healthcare provider and research staff.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Enhanced Pre-Consent Discussion</intervention_name>
    <description>The enhanced pre-consent discussion intervention is a tool that includes both textual and graphical information regarding the trial and an interactive component designed to initiate and facilitate conversations between all parties in the decision—parent, patient, healthcare provider and research staff.</description>
    <arm_group_label>Enhanced Pre-consent Discussion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Pre-consent Discussion</intervention_name>
    <description>Standard pre-consent discussion for a clinical trial</description>
    <arm_group_label>Standard Pre-consent Discussion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parent of a child who is eligible for the COMBINE trial (ClinicalTrials.gov
             Identifier: NCT02772965)

          -  Patient who is eligible for the COMBINE trial (ClinicalTrials.gov Identifier:
             NCT02772965)

        Exclusion Criteria:

          -  Non-English speaking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ellen Lipstein, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ellen A Lipstein, MD, MPH</last_name>
    <phone>514-803-1626</phone>
    <email>ellen.lipstein@cchmc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>William B Brinkman, MD, MEd, MSc</last_name>
    <phone>513-636-2576</phone>
    <email>bill.brinkman@cchmc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cassandra Dodds, MD, MPH</last_name>
      <phone>513-803-3144</phone>
      <email>cassandra.dodds@cchmc.org</email>
    </contact>
    <investigator>
      <last_name>Ellen Lipstein, MD, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2016</study_first_submitted>
  <study_first_submitted_qc>August 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2016</study_first_posted>
  <last_update_submitted>January 24, 2018</last_update_submitted>
  <last_update_submitted_qc>January 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital Medical Center, Cincinnati</investigator_affiliation>
    <investigator_full_name>Ellen A. Lipstein MD, MPH</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatrics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

